At present, immune checkpoint therapy is used as a cancer therapy in addition to radiation, chemotherapy, and surgery and includes the blocking of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) [37]. The gene discussed is CTLA4; the disease is cancer.